SCHEMBL21628537

SCHEMBL21628537

O=C(NO)c1ccc(Oc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
RAB9A P51151 1/20 0.51
HDAC6 Q9UBN7 5/20 0.50
CNR2 P34972 1/20 0.48
NPC1 O15118 1/20 0.48
SERPINE1 P05121 1/20 0.47
HIF1A Q16665 4/20 0.46
EPAS1 Q99814 3/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 1/20 0.46
CASP2 P42575 1/20 0.44
MDH1 P40925 1/20 0.44
MDH2 P40926 1/20 0.44
EP300 Q09472 1/20 0.44
CYP2C9 P11712 1/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628474 0.87 HPGD (0.61) MEN1KMT2ARAB9ACNR2NPC1
SCHEMBL21628411 0.85 HDAC6 (0.47) MEN1KMT2ARAB9AHDAC6NPC1
SCHEMBL21628401 0.84 HDAC6 (0.48) MEN1KMT2ARAB9AHDAC6CNR2
SCHEMBL19362904 0.84 MEN1 (0.55) MEN1KMT2ARAB9ANPC1SERPINE1
SCHEMBL23210638 0.83 HIF1A (0.64) MEN1KMT2ARAB9ACNR2NPC1
SCHEMBL21628735 0.82 KMT2A (0.61) MEN1KMT2ARAB9ANPC1HIF1A
SCHEMBL27845478 0.81 LMNA (0.61) MEN1KMT2ARAB9ANPC1HIF1A
SCHEMBL21657041 0.79 HDAC6 (0.43) MEN1KMT2ARAB9AHDAC6HIF1A
SCHEMBL21628884 0.79 ALDH1A1 (0.61) MEN1KMT2ARAB9ANPC1HIF1A
SCHEMBL21752960 0.79 MEN1 (0.50) MEN1KMT2ARAB9ANPC1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK MEN1 4341/4885KMT2A 313/4885RAB9A 2955/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK MEN1 4341/4885KMT2A 313/4885RAB9A 2955/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK MEN1 4012/4885KMT2A 248/4885RAB9A 3345/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK MEN1 4341/4885KMT2A 313/4885RAB9A 2955/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR MEN1 3190/4885KMT2A 2027/4885RAB9A 3981/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK MEN1 4341/4885KMT2A 313/4885RAB9A 2955/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK MEN1 4341/4885KMT2A 313/4885RAB9A 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.